相关实验视频
Updated: Jan 18, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
913
错过目标:对使用百分比体重减轻来控制肥胖的广泛审查
Diana Sherifali1, Megan Racey1, Donna Fitzpatrick-Lewis1
1McMaster Evidence Review and Synthesis Team; School of Nursing, McMaster University, Hamilton, Ontario, Canada.
概括
大多数肥胖管理研究使用百分比减肥目标,但这些对参与者来说往往是不可行的. 未来的研究应该优先考虑以患者为中心的参数,以实现更可持续的肥胖干预.
科学领域:
- 肥胖研究的研究.
- 体重管理干预措施 体重管理干预措施
- 健康研究成果研究结果
背景情况:
- 在肥胖管理研究中,了解百分比减肥目标的起源和应用是至关重要的.
- 现有的目标可能与患者现实或长期健康益处不一致.
研究的目的:
- 综合现有的关于成人肥胖管理研究中使用的百分比减肥目标的文献.
- 批判性地评估这些目标与它们相关的健康益处相关.
主要方法:
- 使用主要数据库 (Cochrane,MEDLINE,EMBASE) 进行了全面的范围审查.
- 包括的研究重点是针对肥胖成年人的药物或行为干预措施,旨在减少百分比的体重.
- 数据提取包括研究特征和目标减肥参数.
主要成果:
- 包括30项研究 (1992-2024年),主要是RCT和准实验设计.
- 大多数研究的目标是3-10%的体重减轻;一些研究的目标是15%或30%.
- 实现目标的差异很大 (5.9%-85%),目标选择的理由也各不相同.
结论:
- 目前的百分比减肥目标对于肥胖的人来说往往是不可行或不可持续的.
- 纳入以患者为中心的指标对于开发更有效,更全面的肥胖管理策略至关重要.
- 未来的研究和临床实践应该采用更加个性化和以患者为中心的参数.
相关概念视频
Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322

